Top Page
Dai-ichi Life Holdings
(8750)
Dai-ichi Life Holdings (8750) vs. iShares MSCI Japan ETF (EWJ)
Dai-ichi Life Holdings Business Overview & Revenue Model
Dai-ichi Life Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.48T | 8.80T | 10.49T | 8.41T | 7.86T | 7.57T |
| Gross Profit | 8.48T | 8.80T | 10.49T | 8.41T | 7.86T | 7.57T |
| EBITDA | 502.89B | 611.61B | 565.73B | 395.01B | 591.04B | 589.33B |
| Net Income | 337.54B | 429.61B | 320.76B | 173.74B | 409.35B | 363.78B |
Balance Sheet | ||||||
| Total Assets | 68.59T | 69.59T | 67.54T | 61.58T | 65.88T | 63.59T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.89T | 2.06T | 1.62T | 2.18T | 1.88T |
| Total Debt | 1.14T | 1.19T | 975.29B | 949.67B | 870.38B | 899.77B |
| Total Liabilities | 65.01T | 66.12T | 63.66T | 58.71T | 61.47T | 58.79T |
| Stockholders Equity | 3.58T | 3.47T | 3.88T | 2.66T | 4.41T | 4.81T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 532.46B | 946.24B | -250.35B | -561.54B | -118.07B |
| Operating Cash Flow | 0.00 | 592.58B | 997.38B | -132.49B | -462.08B | -79.90B |
| Investing Cash Flow | 0.00 | -968.03B | -644.92B | 117.10B | 940.87B | 615.10B |
| Financing Cash Flow | 0.00 | -73.57B | -145.76B | -325.45B | -180.71B | 65.59B |
Dai-ichi Life Holdings Technical Analysis
Dai-ichi Life Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $4.29T | 18.55 | ― | 2.90% | 11.37% | 27.90% | |
72 Outperform | ¥1.44T | 11.13 | ― | 2.58% | -21.38% | 58.05% | |
69 Neutral | $4.00T | 11.85 | 10.61% | 3.37% | -8.02% | 5.21% | |
69 Neutral | $5.02T | 6.86 | 16.44% | 2.63% | 23.01% | 2.59% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $6.22T | 14.83 | 4.49% | 2.72% | 2.17% | 9.55% | |
61 Neutral | ¥1.75T | 13.59 | 8.83% | 2.92% | -1.96% | 10.32% |
Dai-ichi Life Holdings Corporate Events
Dai-ichi Life Holdings announced corrections to its previous notice regarding the repurchase of its shares. The correction involves the period of repurchase, which has been adjusted to end on March 31, 2026, instead of the initially stated May 31, 2026. This adjustment may impact the company’s financial strategies and shareholder relations.
Dai-ichi Life Holdings announced the repurchase of 5,738,100 shares of its common stock, amounting to approximately 7 billion yen, conducted through open-market transactions in November 2025. This move is part of a broader repurchase plan approved in May 2025, aiming to buy back up to 200 million shares by March 2026, reflecting the company’s strategy to enhance shareholder value and optimize capital structure.
Dai-ichi Life Holdings has completed the payment related to the issuance of new shares as part of a performance-linked stock compensation scheme. This move, approved by the Board of Directors, involves issuing 280,400 shares of common stock, aimed at aligning the interests of the company’s directors and executive officers with its performance, potentially impacting its market positioning and stakeholder engagement.
Dai-ichi Life Holdings announced the completion of a reinsurance transaction by its subsidiary, Protective Life Corporation, which has resulted in a significant increase in the company’s consolidated total assets by USD 6.7 billion. This transaction reflects a 25.6% increase in consolidated net assets as of March 2024, highlighting the company’s strategic efforts to enhance its financial position and asset base.
Dai-ichi Life Holdings has revised its consolidated earnings and dividend forecasts for the fiscal year ending March 31, 2026, citing increased gains on sales of securities due to robust stock prices. The company expects higher ordinary revenues, profits, and net income, leading to an increase in the year-end dividend forecast from 24 yen to 27 yen per share, reflecting a positive outlook for stakeholders.
The Neo First Life Insurance Company, a subsidiary of Dai-ichi Life Holdings, reported its financial results for the six months ending September 30, 2025. The announcement provides detailed insights into the company’s financial health, including investment results and solvency margin ratio, which are crucial for stakeholders to assess the company’s stability and performance.
Dai-ichi Frontier Life Insurance Co., Ltd., a subsidiary of Dai-ichi Life Holdings, has announced its financial results for the six months ending September 30, 2025. The release provides detailed insights into the company’s financial performance, including investment results, balance sheet, and profit breakdown, which are crucial for stakeholders to assess the company’s financial health and strategic positioning in the insurance market.
Dai-ichi Life Holdings announced its financial results for the six months ending September 30, 2025, highlighting key financial metrics and performance indicators. The release provides insights into the company’s operational efficiency and financial health, which are crucial for stakeholders assessing the company’s market positioning and future prospects.
Dai-ichi Life Holdings reported a mixed financial performance for the six months ending September 30, 2025, with a decline in group fundamental profit by 10.7% compared to the previous year. Despite this, the company saw a positive increase in its solvency margin ratio, indicating a stronger financial position, which may reassure stakeholders about its long-term stability.
Dai-ichi Life Holdings reported a decrease in ordinary revenues and profits for the six months ended September 30, 2025, compared to the same period in the previous year. Despite a challenging financial performance, the company announced a revision in its dividend forecasts and earnings projections for the fiscal year ending March 31, 2026, indicating strategic adjustments to enhance shareholder value and stabilize its financial outlook.
Dai-ichi Life Holdings announced that it did not repurchase any of its shares in October 2025, despite having a board-approved plan to buy back up to 200 million shares by May 2026. This lack of repurchase activity could indicate a strategic decision to hold off on buybacks, potentially affecting shareholder expectations and market perceptions.
Dai-ichi Life Holdings, Inc. announced its decision to acquire a substantial shareholding in Wealth Management, Inc., amounting to 28.47% of total voting rights. This strategic acquisition is expected to enhance Dai-ichi Life’s market position and expand its influence in the wealth management sector, potentially impacting its operations and stakeholder interests.
Dai-ichi Life Holdings announced the repurchase of 5,618,400 shares of its common stock for approximately 6.9 billion yen, conducted through open-market transactions in September 2025. This move is part of a broader share buyback program authorized by the board, which allows for the repurchase of up to 200 million shares, highlighting the company’s strategy to enhance shareholder value and optimize capital allocation.